Welcome to LookChem.com Sign In|Join Free
  • or
N-ethyl-N-(3,3,3-trifluoro-2-hydroxy-2-(phenylmethylaminomethyl)propyl)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1034141-47-3

Post Buying Request

1034141-47-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1034141-47-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1034141-47-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,1,4 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1034141-47:
(9*1)+(8*0)+(7*3)+(6*4)+(5*1)+(4*4)+(3*1)+(2*4)+(1*7)=93
93 % 10 = 3
So 1034141-47-3 is a valid CAS Registry Number.

1034141-47-3Relevant academic research and scientific papers

Efficient synthesis of an α-trifluoromethyl-α-tosyloxymethyl epoxide enabling stepwise double functionalisation to afford CF3-substituted tertiary alcohols

Keeling, Steven P.,Campbell, Ian B.,Coe, Diane M.,Cooper, Tony W.J.,Hardy, George W.,Jack, Torquil I.,Jones, Haydn T.,Needham, Deborah,Shipley, Tracy J.,Skone, Philip A.,Sutton, Peter W.,Weingarten, Gordon A.,Macdonald, Simon J.F.

, p. 5101 - 5104 (2008/12/22)

The efficient synthesis of an α-trifluoromethyl-α-tosyloxymethyl epoxide is reported. This highly versatile building block may be reacted sequentially with two different nucleophiles to furnish α-trifluoromethyl tertiary alcohols. Furthermore, the two enantiomers of this key intermediate have been separated using chiral HPLC and the stereochemistry shown to be conserved during subsequent chemical manipulations. Finally, an enzyme-driven desymmetrisation approach has been successfully employed to confer chirality on an intermediate in the sequence.

PYRAZOLE DERIVATIVES AS NON-STEROIDAL GLUCOCORTICOID RECEPTOR LIGANDS

-

Page/Page column 61, (2008/12/06)

The present invention provides compounds of formula (I), a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates, and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1034141-47-3